|
Kimberly Cogdell received her undergraduate degree in molecular biology from Hampton University and her juris doctor from the University of North Carolina at Chapel Hill. She has also done graduate work in biology/biomedical sciences and public health, specializing in health policy and administration. She teaches Bioethics, Antitrust, and Health Law. She will be teaching courses in Scientific Evidence and Comparative Bioethics this year. In addition to her teaching responsibilities, Professor Cogdell is the co-founder of the Biotechnology and Pharmaceutical Law Institute (BPLI) and coordinates many program development activities for the law school. She is also the former chair and current member of the Institutional Review Board at NCCU. Her area of research interest involves the law surrounding genetic manipulation, stem cell transplants, and artificial reproductive technology. She is also interested in health disparities and chronic conditions in vulnerable populations, and international development in Latin America.
|